Oppenheimer Reiterates CalciMedica (CALC) at Outperform, 'We would build a position'
Tweet Send to a Friend
Oppenheimer analyst Leland Gershall reiterated an Outperform rating and $20.00 price target on CalciMedica (NASDAQ: CALC).The analyst commented: "We convened ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
